Division of Hematology

Research

Are you a patient?

Faculty Research Areas

    • Adoptive Cellular TherapiesChimeric Antigen Receptors
    • NF-kB Signaling
    • AIDS-Associated Malignancies
    • Animal Models of Lymphoma and Myeloma
    • Molecularly Targeted Therapies
    • Role of Angiogenesis in Malignant Disease
    • Development of Novel Anti-Angiogenic Compounds
    • Therapeutic Aspects of Kaposi’s Sarcoma
    • Malignant and Benign Hematologic Disorders
    • Preclinical Drug Development
    • Myeloma
    • Lymphoma
    • Acute Myeloid Leukemia
    • Heparin-Induced Thrombocytopenia in Vascular Surgery
    • Role of ADAMTS 13 in Vascular Disease
    • Thromboembolism Secondary to Chemotherapy and Cancer
    • Thrombopoeitic Agents in the Management of Immune
    • Thrombocytopenic Purpura
    • KSHV-Associated Malignancies
    • Drug Development
    • Multiple Myeloma
    • Immunotherapy of B-Cell Cancers
    • Phase I/II Trials of New Agents for Hematologic Malignancies
    • Blood Clotting Disorders
    • Cancer-Related Thrombosis
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasms
    • Hemostasis Abnormalities in Cancer Patients
    • Anemia
    • Multiple Myeloma
    • Plasma cell dyscrasias
    • Healthcare Policy /Meta Analyses

Collaborative Information

For people interest in collaborating with this Division, the research is Preet M. Chaudhary, MD, PhD (pre-clinical) and Kevin Kelly, MD, PhD (clinical).

Members of the Hematology Division are conducting research in several areas of benign and malignant hematology. In particular, Division faculty members have special strengths in basic, translational and clinical research in the areas of adoptive cellular therapy (Chimeric Antigen Receptor T cells) and viral associated malignancies, including those seen in patients with HIV/AIDS. Members of the Division are also involved in a number of innovative investigator-initiated and National Cooperative Group (e.g., SWOG, AMC) sponsored clinical studies. These trials reflect the broad research interests of the Division’s faculty and cover diverse areas, such as conventional chemotherapeutics, small molecules and monoclonal antibodies.

    • Preet M. Chaudhary, MD, PhD, Professor and Chief of Hematology and Director of Blood and Marrow Transplant
      • Chimeric Antigen Receptor T cells (CAR-T); Novel assays for assaying the expression and activity of CAR-T cells; HIV-associated malignancies
    • Howard Liebman, MD, Professor of Medicine
      • Cancer Thrombosis
    • Parkash Gill, MD, Professor of Medicine
      • EphB4 and new drug development
    • Kevin Kelly, MD, PhD, Associate Professor of Clinical Medicine, Assistant Director of Clinical Investigations Support Office
      • Targeting protein homeostasis in Acute Myeloid Leukemia, immunotherapies in Multiple Myeloma
    • Casey O’Connell, MD, Associate Professor of Clinical Medicine
      • Clinical and translational research in Myeloid Disorders
    • Ann Mohrbacher, MD, Associate Professor of Medicine
      • Clinical trials in lymphoma myeloma
    • Ilene Weitz, MD, Associate Professor of Medicine
      • Clinical research in cancer related thrombosis, PNH and non-malignant hematology
    • Caroline Piatek, MD, Assistant Professor of Medicine
      • Clinical research in cancer related thrombosis and non-malignant hematology.
    • George Yaghmour, MD, Assistant Professor of Medicine
      • Clinical research in Acute Leukemia with a focus in Acute lymphocytic Leukemia and allogeneic stem cell transplant
    • Zaw Myint, MD, Assistant Professor of Medicine
      • Clinical research in Acute Leukemia and allogeneic stem cell transplant
    • Anil Tulpule, MD, Associate Professor of Clinical Medicine
      • AIDS malignancies, lymphoma and Kaposi sarcoma